Skip to main content

Clinical trial

A Phase 2b, Randomized, Double-blind, Single-dose, Active-controlled, Dose Ranging Study to Evaluate the Efficacy and Safety of MEDI8852 in Adults who are Hospitalized with Influenza Caused by Type A Strains

Cancers
Organ solid tumors
Trial status Trials closed
Investigator
Trial type
Prospective interventional
Phase Trial phase 2
Academic trial Non
Sponsor MedImmune LLC
EudraCT Identifier 2015-004276-29
ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT03028909
Last update

Follow us!

Support research

Support research

Research at the Institut Jules Bordet depends on your generosity. Make a donation today and join us in the fight against cancer.

Learn more